-
Now that Lilly has a cheaper generic Humalog, will Novo Nordisk and Sanofi follow?
fiercepharma
March 08, 2019
Caught by an outcry over high insulin prices, Eli Lilly recently unveiled an authorized generic version of its Humalog insulin at half the price of the original brand.
-
Lilly answers insulin price-hike critics with 50% off Humalog generic
fiercepharma
March 07, 2019
Eli Lilly CEO David Ricks' absence from last week’s Senate Finance Committee hearing on drug prices didn’t go unnoticed.
-
Lilly introduces cheaper generic insulin in the US
europeanpharmaceuticalreview
March 06, 2019
The generic version will cost 50 percent less that the current Humalog list price…
-
Lupin launches chronic angina treatment drug in the US
expressbpd
March 01, 2019
The newly-launched product, in strengths of 500 mg and 1,000 mg, is a generic version of Gilead Sciences’ Ranexa ER tablets
-
Mylan's 'aggressive' generic Advair discount isn't as big as it looks: analysts
fiercepharma
February 24, 2019
If Mylan’s aggressive pricing for its generic Advair product sounds familiar, that’s because it is.
-
EU measures in support of generic pharmaceuticals producers
europeanpharmaceuticalreview
February 22, 2019
The EU is adopting new rules which should boost the competitiveness of EU producers of generic medicines and biosimilar products…
-
US top court denies Indivior’s request on suboxone, Dr Reddy’s gains Hyderabad
expressbpd
February 21, 2019
Indivior is in legal battle against the launch of copycat version of its opioid addiction treatment by competitors including Dr Reddy’s Laboratories in the US market
-
Sales of generic oncology drugs surge
europeanpharmaceuticalreview
February 21, 2019
A report has forecasted that the generic oncology drugs market could register an impressive 6 percent CAGR up to the year 2028…
-
Glenmark receives ANDA approval for sevelamer hydrochloride tablets
expressbpd
February 12, 2019
Sevelamer is indicated to patients with severe kidney disease to lower high blood phosphorus levels
-
Mylan's generic version of ADVAIR DISKUS for asthma, COPD patients gets FDA approval
biospectrumasia
February 02, 2019
The European Medicine Agency has launched a six month consultation on the principles that will form the basis of the electronic product information (ePI)…